A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique

NCT05606757 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Ventral Hernia
Abdominal Hernia

Interventions

DRUG: BOTOX Dose A
DRUG: Placebo for BOTOX
DRUG: BOTOX Dose B
DRUG: BOTOX Dose C

Sponsor

AbbVie